Cipla gets DCGI nod to launch repurposed drug Favipiravir for COVID-19

Cipla has sought approval from the Drug Controller General of India (DCGI) to make and sell favipiravir in an effort for COVID-19 treatment.

The post Cipla gets DCGI nod to launch repurposed drug Favipiravir for COVID-19 appeared first on BioTech Times.

Source

About the Author: Biotech Today

You might like